ArticleCancer medicine2025

Association Between Immune-Related Adverse Events and Treatment Outcomes in Advanced Gastric Cancer Patients Receiving Nivolumab Plus Chemotherapy: A Retrospective Study.

Kazumasa Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.